Literature DB >> 25518009

Hyperactivity in the Gunn rat model of neonatal jaundice: age-related attenuation and emergence of gait deficits.

John A Stanford1, Jeffrey M Shuler1, Stephen C Fowler2, Kimberly G Stanford1, Delin Ma1, Douglas C Bittel3, Jean-Baptiste Le Pichon4, Steven M Shapiro4.   

Abstract

BACKGROUND: Neonatal jaundice resulting from elevated unconjugated bilirubin occurs in 60-80% of newborn infants. Although mild jaundice is generally considered harmless, little is known about its long-term consequences. Recent studies have linked mild bilirubin-induced neurological dysfunction (BIND) with a range of neurological syndromes, including attention-deficit hyperactivity disorder. The goal of this study was to measure BIND across the lifespan in the Gunn rat model of BIND.
METHODS: Using a sensitive force plate actometer, we measured locomotor activity and gait in jaundiced (jj) Gunn rats versus their nonjaundiced (Nj) littermates. Data were analyzed for young adult (3-4 mo), early middle-aged (9-10 mo), and late middle-aged (17-20 mo) male rats.
RESULTS: jj rats exhibited lower body weights at all ages and a hyperactivity that resolved at 17-20 mo of age. Increased propulsive force and gait velocity accompanied hyperactivity during locomotor bouts at 9-10 mo in jj rats. Stride length did not differ between the two groups at this age. Hyperactivity normalized, and gait deficits, including decreased stride length, propulsive force, and gait velocity, emerged in the 17-20-mo-old jj rats.
CONCLUSION: These results demonstrate that, in aging, hyperactivity decreases with the onset of gait deficits in the Gunn rat model of BIND.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25518009      PMCID: PMC4346430          DOI: 10.1038/pr.2014.199

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


Introduction

Neonatal jaundice resulting from elevated levels of unconjugated bilirubin (UCB) occurs in up to 85% of newborns (1). When UCB levels exceed the binding capacity of albumin, free bilirubin can enter the brain where it targets discrete nuclei, including the globus pallidus, cochlear nucleus and inferior colliculus, hippocampus, and cerebellum. Free bilirubin is toxic at elevated levels, resulting in a constellation of devastating and permanent neurological effects known as kernicterus (2). Little is known, however, about the long-term consequences of more subtle levels of neonatal jaundice. Emerging evidence supports a subtle-kernicteric syndrome that is referred to as bilirubin-induced neurological dysfunction (BIND). BIND has been linked to a range of neuropsychiatric syndromes that persist into adulthood, including attention deficit-hyperactivity disorder, autism, and schizophrenia (3–6). Even with modest co-morbidities, the incidence of neonatal jaundice justifies further exploration of links between these disorders and BIND. The goal of this study was to measure locomotor activity and gait across the lifespan in the Gunn rat model of BIND (7). Gunn rats are genetically deficient of UDP glucuronosyl transferase, the liver enzyme responsible for bilirubin conjugation and clearance. These rats become jaundiced soon after birth and exhibit physical, neurological and behavioral abnormalities. Their blood bilirubin levels peak at 16 days postnatal age and fall to lower but elevated levels throughout the rest of their lives (8–11). Although Gunn rats model classical kernicterus when administered sulfa during discrete postnatal time periods (9; 12–14), untreated Gunn rats are a model of BIND. The most apparent abnormalities during the early postnatal days are their smaller size and hyperactive phenotype (15). More subtle and variable deficits include attention and learning deficits, deficits in social behavior, and anecdotal reports of ataxia (6, 15, 16). Anatomical and histopathological studies report cerebellar hypoplasia, hippocampal mitochondrial abnormalities, and alterations in catecholamines in the basal ganglia and cerebellum of Gunn rats (16–18). Disruptions in the circuitry through which these brain regions interact likely underlie the behavioral deficits that have been reported in this model (reviewed in (5)). Although jaundice peaks during early postnatal days in Gunn rats as it does in humans, we are studying these rats through adulthood and aging to determine long-term sequelae of BIND.

Results

Overall, jj rats maintained significantly lower body weights than their Nj counterparts at all ages (Figure 1A). Locomotor activity was significantly greater in the jj rats at 3–4 months during the initial 15-minute testing sessions, F(1,6)=39.656, p=0.001 (Figure 1 B). This difference between groups persisted across 6 days of testing. When the older groups were tested, locomotor activity remained higher in the 9–10 month jj rats, F(1,6)=8.117, p
Figure 1

(A) Body weight as a function of group and age. At each age, Nj rats’ (filled bars) body weights exceeded those of jj rats (open bars). (B) Distance traveled during 15-min, weekly testing sessions. Rats in the jj group (open symbols) exhibited greater locomotion than Nj rats (filled symbols) on each testing day. *p<0.05, **p<0.01.

Figure 2

Distance traveled and gait measures in adult vs late middle-aged Nj (filled bars) vs jj (open bars) rats. (A) Distance traveled was greater for the 9–10 month-old jj rats, but this effect was not present at 17–20 months. (B) Stride length was diminished in the 17–20-month-old jj group. Compared to Nj rats, run velocity (C) and within-run force range (D) were both greater in the 9–10-month-old jj group, but diminished in the 17–20-month-old jj group. *p<0.05; **p<0.01.

Neither the number of runs, the duration of runs, the length of individual runs, or stride rate differed significantly as a function of group or age (see Table 1). However, for stride length, run velocity, and within run force range, differences emerged between the groups. Stride length was similar between the 9–10 month jj and Nj rats, F(1,6)=1.074, p=0.34, but was significantly decreased in the 17–20 month-old jj rats, F(1,14)=13.22, p<0.01 (Figure 2B). Run velocity was significantly greater in the 9–10-month-old jj rats, F(1,6)=6.061, p<0.05, but was decreased in the older jj group, F(1,15)=10.411, p<0.01 (Figure 2C). Within-run force range was similarly affected, as propulsive force was greater in 9–10 month-old, F(1,6)=27.320, p<0.01, but diminished in 17–20 month-old jj rats, F(1,11)=9.104, p<0.05 (Figure 2D).
Table 1

Gait measures that did not differ significantly between-groups. Data are means ± SEM.

Measure9–10 mosNj9–10 mosjj17–20 mosNj17–20 mosjj
Runs (#)10 ± 213 ± 214 ± 210 ± 2
Duration of Runs (s)1.28 ± 0.051.16 ± 0.031.22 ± 0.131.4 ± 0.05
Run Length (mm)385 ± 8386 ± 14407 ± 17344 ± 16
Stride Rate (Hz)1.91 ± 0.022.06 ± 0.112.10 ± 0.171.99 ± 0.04

Discussion

Overall, jj rats exhibited decreased body weights that persisted across their lifespan, and a hyperactive phenotype that resolved in late middle age. Gait abnormalities, such as decreased stride length, decreased stride velocity and decreased propulsive force, emerged in the 17–20 month-old jj group. These results are consistent with reported effects of neonatal jaundice on hyperactivity, and on basal ganglia, hippocampal, and cerebellar pathology in the Gunn rat model. The hyperactive phenotype exhibited by the jj rats was consistent with previous findings in 60-day-old jj rats (15). Our results extend these findings to older adulthood. We also report for the first time that the hyperactivity produced by neonatal jaundice resolves at late middle age (17–20 months) in the Gunn rat model. Although the neural mechanisms underlying this phenomenon have not been identified, interactions between the basal ganglia and cerebellum may play a role (5). Disruptions of the cortico-cerebellar-basal ganglia circuit would adversely affect appropriate behavioral response selection and inhibition. It is tempting to attribute the decreased hyperactivity in the aged jj rats to normal age-related decreases in basal ganglia function (16–18). However, this hypothesis is not supported by the fact that locomotor activity in Nj rats did not decrease between the 9–10-month and the 17–20-month-old groups. Because age-related decreases in locomotor activity are typically present by 18 months of age in rats (19), our findings suggest potential behavioral abnormalities in non-jaundiced littermates. The addition of a control group with full UDP glucuronosyl transferase activity is necessary to test this hypothesis. Alternatively, there is pathological evidence for damage to the hippocampus in Gunn rats (18). Lesions of the ventral hippocampus result in hyperactivity in adult rats (22–25), so it is possible that toxic effects of UCB in the hippocampus contributed to – if not accounted for – the hyperactive phenotype. It is well documented that hyperactivity following damage to the hippocampus during early postnatal periods is delayed, emerging in young adult rats (23, 24). Although speculative, these previous findings are consistent with hippocampal involvement in the hyperactivity we measured in jj rats. Further studies examining neural activity in affected structures are clearly warranted to test these hypotheses. Gait deficits, including decreased stride length, are present in a number of neurological conditions with different underlying pathologies, including Parkinson’s disease (26), Huntington’s disease (27), and Amyotrophic Lateral Sclerosis (28). Although lesions in the areas affected in each of these conditions likely disrupt motor-related circuits through the cerebellum, basal ganglia and cortex, anatomical and pathological studies in Gunn rats support a primary role for cerebellar dysfunction in the gait deficits we observed (16). The fact that we did not detect significant differences in stride length or other gait parameters in our 9–10 month-old group was surprising, but consistent with studies that have quantified gait in this model (29). Although other groups have reported a wobbly gait or ataxia in young Gunn rats (15, 30, 31), these reports have been observational. We also observed and quantified a wobbly gait in some, but not all, of the younger Gunn rats in our study (data not shown). Gait abnormalities and motor incoordination might be expected earlier in humans, but the timing is different in Gunn rats than most humans with hyperbilirubinemia. In Gunn rats, bilirubin peaks at about 12 mg/dL at 16 days of age (9) but remains elevated throughout life. The abnormalities we found may be a delayed effect of the neonatal peak, but perhaps the chronic levels are in part responsible for later responses. In addition, concurrent illness (e.g., viral infections) can exacerbate bilirubin neurotoxicity in jaundiced Gunn rats with minimal signs of neurotoxicity. Over time, these may have contributed to the later emerging symptoms. We did not measure cerebellar damage or hypoplasia, but these phenomena are features in these rats as early as 7–10 days of postnatal age (32, 33). It is possible that compensation accounted for the lack of gait abnormalities in our 9–10 month-old group. For example, previous studies demonstrate that aging has a detrimental effect on cerebellar-specific motor learning and exacerbates ataxia resulting from cerebellar lesions (34–36). For example, anatomical reorganization and functional recovery is greater following cerebellar damage in the neonate than in the adult rat (34, 35). Although 9–10 month-old rats are adults, the cerebellar lesions present in Gunn rats are likely less severe than those produced experimentally in the cited studies. Despite the presence of visible ataxia in some of our jj rats throughout their lifespan, our results suggest that the toxic effects of neonatal jaundice on cerebellar circuits may go undetected until these circuits are further perturbed by the effects of normal aging (e.g., decreased beta adrenergic receptor function, impaired motor learning) on cerebellar function (36). Previous studies have cited co-morbidities between neonatal jaundice and various neuropsychiatric disorders, including ADHD (3–6). Damage to the globus pallidus, hippocampus and cerebellum in BIND is consistent with clinical findings of abnormalities in each of these regions in ADHD (37, 38). Our findings support a link between BIND and ADHD in that, as in the clinical situation, hyperactivity generally resolves with increased age (3, 39). We believe that the human correlate for what we measured is hyperactivity or perhaps ADHD. While speculative, we hypothesize that BIND results in an ADHD phenotype in young Gunn rats until it is attenuated by gait abnormalities due to cerebellar dysfunction in aging. One potential weakness of our study was the lack of bilirubin measurements in our jj and Nj groups. The value of total (vs unbound, or free) bilirubin in predicting BIND is questionable, however (40), and measurement techniques for free bilirubin are in their infancy. In addition, we did not measure auditory dysfunction in our study. Changes in brainstem auditory evoked potentials have been measured in neonatal and young adult Gunn rats (14) and were likely present in our rats. To our knowledge, auditory function has not been measured in older Gunn rats. Given the significant incidence of neonatal jaundice, additional studies are needed to further validate this model and to determine how BIND relates to ADHD and to ataxia in the elderly.

Methods

Animals

Male jj or Nj rats were studied at 3–4 months of age, 9–10 months of age, or 17–20 months of age. We limited our study to male rats due to the increased risk of hyperbilirubinemia in males (41). We did not generate an NN strain with full UDP glucuronosyl transferase activity to use as controls as Nj rats have not been shown to exhibit physical or neurological abnormalities. For the 3–4 months and 9–10 months groups, we used 4 jj rats and 4 Nj rats. For the 17–20 months groups, we used 12 jj rats and 4 Nj rats (we tested more jj rats because we kept more of them in our colony longer than their Nj littermates). Distance traveled was measured in all groups, but gait was only measured in the 9–10 and 17–20 months-old groups because meticulous paw print analyses have revealed that younger jj and Nj rats do not differ with regard to stride length (29). Animals were housed in the University of Kansas Medical Center’s (KUMC’s) AAALAC-accredited animal facility, and all procedures adhered to the policies put forth in the Guide for the Care and Use of Laboratory Animals (2011) and were approved by the KUMC Institutional Animal Care and Use Committee.

Locomotor activity and gait

The force plate actometer was constructed in-house and had an 80 cm × 80 cm floor that recorded ground reaction forces as rats moved individually around the arena for 60 min. The animal’s center of force was quantified using Cartesian coordinates derived from the locations of the four force sensors that were rigidly attached to each corner of the actometer surface (see (42)). Distance traveled was quantified based on changes in the rat’s center of force during each session. Force transducer voltages were digitized at the rate of 100 samples/s, and ground reaction forces were expressed as percent of body weight. We initially analyzed distance traveled in the 3–4 month groups across six 15-min sessions one week apart. For the older groups, sessions were 60 min in duration to allow for measurements of gait patterns made possible by the large size of the actometer. A scrolling graphics program written in-house was used to visualize, count, and record consecutive force-time variations that constituted half strides. Temporally aligned on the same screen with the force data were the rat’s location coordinates, which allowed the observer to identify and record only rhythmic, long, straight, fast, continuous runs and their associated force time series (see two examples depicted in Figure 3). Each cycle is a half stride. In the figure, the numbers 1 through 6 give the temporal order of half stride production. A rhythmic sequence of four or more half strides constituted a run where diagonally opposite feet act in unison to produce alternating stance and swing phases (Figure 3). In order to be considered suitable for quantitation, four or more half strides (i.e., two full strides was the minimum) had to be discerned by the program user. Additional criteria for including a run in the data set for estimation of gait parameters were: i) A run had to be reasonably straight. This was judged by the program user by noting the lack of curvature in X(t) and/or Y(t) during the run sequence of half strides. This criterion ensured that variation in rhythm and other gait parameters would not be the result of changing direction at corners, etc. ii) A run had to be expressed as a continuous sequence of half strides without any pausing in locomotion. iii) Rhythmic sequences of force variation, such as those produced by grooming or scratching were easily excluded from scoring because these in-place behaviors were not accompanied by locomotion. These data, which were saved in an Excel file, were subjected to further processing in SYSTAT in order to calculate the number of runs, duration of run, stride length (run distance/number of strides), stride rate (strides/second), velocity (run distance/run duration), within-run force range (maximum – minimum force), run distance (measured directly using scrolling graphics program), and number of half strides/run (measured directly using scrolling graphics program). Each of these parameters was then averaged across runs for each rat. Analysis of variance (ANOVA) was used to compare jj vs Nj groups. ANOVAs were conducted separately for each age group, and p<0.05 was considered statistically significant.
Figure 3

Changes in center of force and raw force-time records illustrating one run from one representative 20-month-old Nj rat (left) and one representative 20-month-old jj rat (right). (A) Center of force measures indicate the run distance for the Nj rat. Numbers 1–6 along the relatively straight line along the y axis refer to the sequential order of half strides. (B) The graph shows changes in the Nj rat’s vertical force during the run shown in panel A. The numbers 1–6 refer to the 6 half strides depicted in Panel A. Two examples of stance and swing phases are indicated. (C) Center of force measures indicate the run distance for the jj rat. Numbers 1–6 along the relatively straight line along the×axis refer to the sequential order of half strides. (D) The graph shows changes in the jj rat’s vertical force during the run shown in panel C. The numbers 1–6 refer to the 6 half strides depicted in Panel C. Two examples of stance and swing phases are indicated.

  40 in total

1.  Quantitative analysis of gait in Parkinson patients: increased variability of stride length.

Authors:  O Blin; A M Ferrandez; G Serratrice
Journal:  J Neurol Sci       Date:  1990-08       Impact factor: 3.181

Review 2.  Toward understanding kernicterus: a challenge to improve the management of jaundiced newborns.

Authors:  Richard P Wennberg; Charles E Ahlfors; Vinod K Bhutani; Lois H Johnson; Steven M Shapiro
Journal:  Pediatrics       Date:  2006-02       Impact factor: 7.124

Review 3.  Bilirubin-induced neurologic damage--mechanisms and management approaches.

Authors:  Jon F Watchko; Claudio Tiribelli
Journal:  N Engl J Med       Date:  2013-11-21       Impact factor: 91.245

Review 4.  Hyperbilirubinemia: current guidelines and emerging therapies.

Authors:  Hamilton P Schwartz; Beth E Haberman; Richard M Ruddy
Journal:  Pediatr Emerg Care       Date:  2011-09       Impact factor: 1.454

5.  Experimental bilirubin encephalopathy. The mode of entry of bilirubin-14C into the central nervous system.

Authors:  I Diamond; R Schmid
Journal:  J Clin Invest       Date:  1966-05       Impact factor: 14.808

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Postpubertal emergence of hyperresponsiveness to stress and to amphetamine after neonatal excitotoxic hippocampal damage: a potential animal model of schizophrenia.

Authors:  B K Lipska; G E Jaskiw; D R Weinberger
Journal:  Neuropsychopharmacology       Date:  1993-08       Impact factor: 7.853

8.  Outcomes in a population of healthy term and near-term infants with serum bilirubin levels of >or=325 micromol/L (>or=19 mg/dL) who were born in Nova Scotia, Canada, between 1994 and 2000.

Authors:  Krista A Jangaard; Deshayne B Fell; Linda Dodds; Alexander C Allen
Journal:  Pediatrics       Date:  2008-07       Impact factor: 7.124

9.  Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats.

Authors:  M A Hebert; G A Gerhardt
Journal:  Brain Res       Date:  1998-06-22       Impact factor: 3.252

10.  Hemicerebellectomy and motor behaviour in rats. III. Kinematics of recovered spontaneous locomotion after lesions at different developmental stages.

Authors:  M Molinari; L Petrosini
Journal:  Behav Brain Res       Date:  1993-03-31       Impact factor: 3.332

View more
  5 in total

1.  Targeted deletion of GD3 synthase protects against MPTP-induced neurodegeneration.

Authors:  Y Akkhawattanangkul; P Maiti; Y Xue; D Aryal; W C Wetsel; D Hamilton; S C Fowler; M P McDonald
Journal:  Genes Brain Behav       Date:  2017-04-18       Impact factor: 3.449

Review 2.  Neuroscience and actometry: An example of the benefits of the precise measurement of behavior.

Authors:  Troy J Zarcone
Journal:  Brain Res Bull       Date:  2022-04-25       Impact factor: 3.715

3.  Use of a force-sensing automated open field apparatus in a longitudinal study of multiple behavioral deficits in CAG140 Huntington's disease model mice.

Authors:  Stephen C Fowler; Nancy A Muma
Journal:  Behav Brain Res       Date:  2015-07-22       Impact factor: 3.332

Review 4.  Developmental influence of unconjugated hyperbilirubinemia and neurobehavioral disorders.

Authors:  Sanjiv B Amin; Tristram Smith; Geralyn Timler
Journal:  Pediatr Res       Date:  2018-10-23       Impact factor: 3.756

5.  Normalizing hyperactivity of the Gunn rat with bilirubin-induced neurological disorders via ketanserin.

Authors:  Shoko Miura; Keiko Tsuchie; Michiyo Fukushima; Ryosuke Arauchi; Toshiko Tsumori; Koji Otsuki; Maiko Hayashida; Sadayuki Hashioka; Rei Wake; Tsuyoshi Miyaoka; Masatoshi Inagaki; Arata Oh-Nishi
Journal:  Pediatr Res       Date:  2021-03-31       Impact factor: 3.756

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.